Michael Dial

Michael Dial is an Industry Advisory Board Member and Professor of the Practice at the Kenan-Flagler Business School at the University of North Carolina at Chapel Hill. With over 17 years of experience in life science and healthcare sectors, he bridges academic research with venture capital and corporate finance.

Education:

• Ph.D. in Biochemistry and Biophysics from UNC-Chapel Hill

His research background spans proteomics, cancer therapy, and cell cycle regulation, derived from positions in the UNC-Duke Michael Hooker Proteomics Center and the National Institute of Environmental Health Sciences. Currently, he focuses on supporting UNC-Chapel Hill-related startups as Manager of L2 Ventures and as a General Partner at Hatteras Venture Partners.

While his academic role involves teaching and advising, no formal publications or scientific awards are explicitly detailed in the provided text.